Menu

Lasker Awards Recognize Work on Histones, Anesthesia, RNA

This year’s winners are C. David Allis, Michael Grunstein, John Glen, and Joan Steitz.

Sep 11, 2018
Shawna Williams
From left to right: C. David Allis, Michael Grunstein, John Glen, and Joan Steitz
ALBERT AND MARY LASKER FOUNDATION

The winners of this year’s Lasker Awards are C. David Allis of Rockefeller University and Michael Grunstein of the University of California, Los Angeles, for discoveries about the proteins that package DNA; John “Iain” Glen, formerly a pharmaceutical researcher at AstraZeneca, for developing the drug propofol; and Yale University’s Joan Steitz for leadership and research throughout her career, the Lasker Foundation announced today (September 11). The Laskers, prestigious awards often used to forecast future Nobel Prize winners, each come with a cash prize of $250,000.

At one time, Grunstein recalled in a teleconference with the media today, most researchers assumed that because the histone proteins that package DNA are highly conserved among vastly different species, they must not be very interesting. But in the 1980s, “we found that they’re very important, not only as packing material, but as proteins that regulate gene activity,” he says. 

Allis and colleagues would later uncover more details about how this regulation works, including an enzyme that removes acetyl tags on histones, changing genes’ expression levels. The work helped lay the foundation for developing drugs for cancer and other conditions that involve aberrant histone tags.

See “Support for Histone Code?

In an interview with Science, Glen, a former veterinarian, recalls how it took 13 years to develop propofol, now one of the world’s most-used anesthetics. “I remember knowing it was special when I saw how quickly the animals recovered after they woke up,” he tells the magazine. “A whole pen of pigs could be out cold one moment, and then digging into their food the next.”

Steitz’s award recognizes not a specific achievement, but her “four decades of leadership in biomedical science,” according to the Lasker’s statement. She is known for her discovery that small nuclear ribonucleoproteins (snRNPs) are key players in splicing finished mRNA transcripts within cells, and for other RNA-related work. 

She has also been an advocate for women in science. “When I started out being excited by science—but seeing that there weren’t any women scientists—I thought I had no prospects whatsoever,” she tells The New York Times. Her aim, she says, is to be “a good citizen and try to help women and other underrepresented people to fulfill their potential.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.